Reduction in the incidence of myocardial infarction with sodium–glucose linked cotransporter-2 inhibitors: evident and plausible

被引：0
|
作者：
Richard E. Gilbert
Kim A. Connelly
机构：
[1] St. Michael’s Hospital,Division of Endocrinology
[2] St. Michael’s Hospital,Division of Cardiology
来源：
Cardiovascular Diabetology | / 18卷
关键词：
Sodium–glucose linked cotransporter-2; Myocardial infarction; Cardiovascular outcome trials; Stroke;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Reduction in the incidence of myocardial infarction with sodium-glucose linked cotransporter-2 inhibitors: evident and plausible
    Gilbert, Richard E.
    Connelly, Kim A.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [2] Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction
    Profili, Nicia I.
    Castelli, Roberto
    Manetti, Roberto
    Sircana, Marta C.
    Pagni, Michela
    Sechi, Gemma Lisa
    Gidaro, Antonio
    Cossu, Costantino
    Bella, Francesco
    Delitala, Alessandro P.
    BIOMEDICINES, 2025, 13 (03)
  • [3] Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction
    Udell, Jacob A.
    Jones, W. Schuyler
    Petrie, Mark C.
    Harrington, Josephine
    Anker, Stefan D.
    Bhatt, Deepak L.
    Hernandez, Adrian F.
    Butler, Javed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 79 (20) : 2058 - 2068
  • [4] Sodium-glucose cotransporter-2 inhibitors: a swinging pendulum in the treatment of acute myocardial infarction
    Aziri, Buena
    Begic, Edin
    Stanetic, Bojan
    Mladenovic, Zorica
    Kovacevic-Preradovic, Tamara
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2024, 72 (03) : 237 - 250
  • [5] Plausible effects of sodium-glucose cotransporter-2 inhibitors on adverse cardiac remodelling
    Berezin, Alexander E.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (11) : E300 - E302
  • [6] Are We Ready for Expanding the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Myocardial Infarction?
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Giannakoulas, George
    Fragakis, Nikolaos
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 84 (01) : 26 - 28
  • [7] Sodium-Glucose Cotransporter-2 Inhibitors in Depression
    Liebers, David T.
    Ebina, Wataru
    Iosifescu, Dan V.
    HARVARD REVIEW OF PSYCHIATRY, 2023, 31 (04) : 214 - 221
  • [8] Gout and sodium-glucose cotransporter-2 inhibitors
    Lai, Shih-Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 112 - 113
  • [9] Effects of sodium-glucose cotransporter-2 inhibitors in myocardial infarction patients: A systematic review and meta-analysis
    Jia, Qiufeng
    Zuo, Ankai
    Song, Hui
    Zhang, Chengrui
    Fu, Xiangrui
    Hu, Keqing
    An, Fengshuang
    DIABETES OBESITY & METABOLISM, 2025, 27 (03): : 1276 - 1286
  • [10] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis
    Anan, Go
    Kikuchi, Daisuke
    Hirose, Takuo
    Ito, Hiroki
    Nakayama, Shingo
    Mori, Takefumi
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 925 - 928
12345